0.3% Tacrolimus gel and 0.5% tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study

Acta Dermato-Venereologica

Volumn 86, Issue 1, 2006, Pages 29-33

  Ortonne, Jean Paul ^a   Van De Kerkhof, Peter C M ^b   Prinz, Jörg C ^c   Bieber, Thomas ^d   Lahfa, Morad ^e   Rubins, Andris ^f   Wozel, Gottfried ^g   Lorette, Gérard ^h  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e SAINT LOUIS HOSPITAL   (France)

^f Latvijas Dermatologijas Instituta   (Latvia)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^h Centre de Pediatrie Clocheville   (France)

Author keywords

Adults; Cream; Gel; Psoriasis; Tacrolimus

Indexed keywords

CALCIPOTRIOL; TACROLIMUS; CALCITRIOL; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

ADULT; APPLICATION SITE BURNING; APPLICATION SITE DRYNESS; APPLICATION SITE ERYTHEMA; APPLICATION SITE PHOTOSENSITIVITY REACTION; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; APPLICATION SITE WARMTH; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DEMOGRAPHY; DISEASE SEVERITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; FEMALE; FLUSHING; GEL; HEADACHE; HUMAN; HYPERTENSION; INFLUENZA; LARYNGITIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL EDEMA; PRIORITY JOURNAL; PRURITUS; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SEBORRHEIC DERMATITIS; SIDE EFFECT; SINGLE BLIND PROCEDURE; SKIN BURNING SENSATION; TREATMENT RESPONSE; ADOLESCENT; AGED; DOSE RESPONSE; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; OINTMENT; PSORIASIS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITRIOL; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GELS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OINTMENTS; PSORIASIS; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME;

EID: 33744734330     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550510039817     Document Type: Article

References (13)

1. Rizova E, Corroller M. Topical calcitriol - studies on local tolerance and systemic safety. Br J Dermatol 2001; 144 (Suppl. 58): 3-10.
2. Nickoloff BJ. The immunologic and genetic basis of psoriasis. Arch Dermatol 1999; 135: 1104-1110.
3. Ortonne JP. Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol 1999; 54: 1-7.
4. Prinz JC. The role of T cells in psoriasis. J Eur Acad Dermatol Venereol 2003; 17: 257-270.
5. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2002; 46: 1-26.
6. Goto T, Kino T, Hatanaka H, Okuhara M, Kohsaka M, Aoki H, et al. FK506: historical perspectives. Transplant Proc 1991; 23: 2713-2717.
7. Tocci MJ, Matkovich DA, Coller KA, Kwok P, Dumont F, Lin S, et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989; 143: 718-726.
8. Hanifin JM, Ling MR, Langley R, Breneman B, Rafal E and the Tacrolimus Ointment Study Group. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, Efficacy. J Am Acad Dermatol 2001; 44: 28-38.
9. Soter NA, Fleischer AB, Webster GF, Monroe E, Lawrence I and The Tacrolimus Ointment Study Group. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, Safety. J Am Acad Dermatol 2001; 44: 39-46.
10. Reitamo S, Harper J, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Valk P, et al. 0.03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol 2004; 150: 554-562.
11. Paller A, Eichenfeld LF, Leung DYM, Stewart D, Appell M and the Tacrolimus Ointment Study Group. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001; 44: 47-57.
12. Aschcroft DM, Wan Po AL, Williams HC, Griffiths CEM. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 1999; 141: 185-191.
13. Reitamo S, Rissanen J, Remitz A, Granlund H, Erkko P, Elg P, et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998; 111: 396-398.